Nexus to build sterile injectable manufacturing facility in Wisconsin

By Akshay Kedari  | Date: 2019-07-12

Nexus to build sterile injectable manufacturing facility in Wisconsin

Nexus Pharmaceuticals, a biopharmaceutical company focused on research & development of critical-need injectable medications, recently revealed plans to invest $250 million to build a sterile injectable manufacturing facility at Pleasant Prairie, in Wisconsin, cite source.

For the record, the company specializes in developing advanced processes to manufacture specialty & generic injectable drugs and will be investing in a facility which will focus on the production & supply of injectable drugs in various therapeutic areas including neurology, anesthesia, cardiovascular and oncology.

Mariam Darsot, Chief Executive Officer of Nexus, was reported to say that this investment is required to drive the growth for the U.S. pharmaceutical manufacturing industry. The firm acknowledges the Wisconsin Economic Development Corp., Kenosha Area Business Alliance, the Milwaukee 7 and the Village of Pleasant Prairie for enabling the firm develop plans for this major expansion project, Darsot added.

With an estimated investment of $250 million, the multi-phase project is expected to be completed in 10 years. Construction is planned to commence in August 2019 & is expected to be completed by 2021. After the facility & manufacturing procedures receive approval from the FDA, commercial production is slated to commence in 2022.

As per sources close to the matter, the initial phase investment of $85 million will support a new, 3-story manufacturing facility with ground-breaking technology including an advanced isolator system that can facilitate maximum product protection & sterility, for reducing the risk of contamination. The new facility will also include multiple freeze-drying (lyophilization) machines to support production of the firm’s present portfolio & robust pipeline of generic & specialty injectable drugs.

Reportedly, the new 100,000 sq. ft. facility is being designed by IPS (Integrated Project Services) with Turner Construction providing construction management services. Both companies have strong backgrounds in design & construction of pharmaceutical manufacturing. The facility is expected to provide for the Wisconsin economy as it is anticipated to create more than 77 new jobs in fields of high technology manufacturing & science by 2022.

Source credits: https://finance.yahoo.com/news/nexus-pharmaceuticals-build-industry-leading-203000066.html

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

McDonald’s to leave Russia after 30 years amidst Ukraine’s invasion

McDonald’s to leave Russia after 30 years amidst Ukraine’s invasion

By Akshay Kedari

After Ukraine’s invasion, multinational fast-food giant McDonald's Corp. is reportedly planning to sell all its restaurants in Russia, pulling operations from the nation after 30 years. The world's biggest fast-food chain closed 847 ...

Berlin’s GetHenry bags USD 17.4 Mn seed funding for business expansion

Berlin’s GetHenry bags USD 17.4 Mn seed funding for business expansion

By Akshay Kedari

GetHenry, a Berlin-based company that offers couriers and logistics organizations electric last-mile delivery bikes, has reportedly raised USD 17.4 million seed round to grow its operations across Europe. The latest investment round was led by LocalG...

Ferrari to equip the upcoming Purosangue with its trademark V12 engine

Ferrari to equip the upcoming Purosangue with its trademark V12 engine

By Akshay Kedari

Italian luxury sports car manufacturer Ferrari S.p.A. will equip its much-awaited Purosangue SUV with a 12-cylinder engine, as it focused more on fuel-efficient models. Confirming the news, Ferrari Chief Executive Benedetto Vigna claimed that the com...

White House to spend USD 3 billion on EV battery manufacturing in U.S.

White House to spend USD 3 billion on EV battery manufacturing in U.S.

By Akshay Kedari

According to reliable sources, the Biden administration is planning to provide USD 3 billion in finance to reinforce EV battery manufacturing capabilities in the United States. The apparent funds will be issued by the Department of Energy from Presid...

Telefonica eyeing Israel’s high-tech sector to improve its portfolio

Telefonica eyeing Israel’s high-tech sector to improve its portfolio

By Akshay Kedari

Telefonica S.A. is planning to increase its investments in Israel’s high-tech sector this year, a senior official reported recently. The company, which is Europe’s third-largest telecommunications company, is also eyeing the country&rsquo...